| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| January 19th, 2006 | 25 | No |
74150-27-9; Acardi (TN); D01133; Pimobendan (JAN/USAN/INN)
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 3.44 | 5.88 | -17.98 | 2 | 6 | 0 | 79 | 334.379 | 3 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| Indications | canine vasodilator, inotropic | KeyOrganics Bioactives |
| Patent Database Links | EP1579862; EP1908469; EP1920785; EP1941872; US2007238762; US2008213283 | ChEBI |
| Target | PDE | Selleck Chemicals |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| PDE3A-1-E | Phosphodiesterase 3A (cluster #1 Of 2), Eukaryotic | Eukaryotes | 410 | 0.36 | Binding ≤ 10μM |
| PDE3B-1-E | Phosphodiesterase 3B (cluster #1 Of 2), Eukaryotic | Eukaryotes | 410 | 0.36 | Binding ≤ 10μM |
| Z102306-1-O | Aorta (cluster #1 Of 6), Other | Other | 4670 | 0.30 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| PDE3A_HUMAN | Q14432 | Phosphodiesterase 3A, Human | 410 | 0.36 | Binding ≤ 1μM |
| PDE3B_HUMAN | Q13370 | Phosphodiesterase 3B, Human | 410 | 0.36 | Binding ≤ 1μM |
| PDE3A_HUMAN | Q14432 | Phosphodiesterase 3A, Human | 410 | 0.36 | Binding ≤ 10μM |
| PDE3B_HUMAN | Q13370 | Phosphodiesterase 3B, Human | 410 | 0.36 | Binding ≤ 10μM |
| Z102306 | Z102306 | Aorta | 4670 | 0.30 | Functional ≤ 10μM |
| Description | Species |
|---|---|
| cGMP effects | |
| G alpha (s) signalling events | |
| PDE3B signalling |